. MicroCT images, Saf-O stained sections, Col II stained sections, and Quantitative T1rho images for sponge-treated defects (A-D) and autografttreated defects (E-H). defects, resulting in repair of the defects with tissue similar in quality to that of autograft-filled defects and improved integration with the surrounding cartilage. Further experimentation is needed to confirm outcome at later timepoints and in larger defects. The safety and efficacy of the allograft sponge has not been validated in human joints. Purpose: Cartilage repair still remains a challenge to the main investigators in the field. Cellular therapy is long far away from the desired regeneration of cartilage for cartilage damage. Our goal is to get MSC from umbilical cord stroma cells and differentiate them to obtain chondrocyte-like cells which could be able transplanted in injured joint to regenerate the tissue. Recent studies from our lab demonstrate that a new model of chondrogenesis in vitro is possible using conditioned medium through the spheroid formation. Methods: The umbilical cord tissues were obtained from caesareans from normal women in the Maternity Facility at Complejo Hospitalario Universitario A Coruña under the supervision of the hospital ethic committee. MSC were isolated and growth from umbilical cord stroma tissue using an enzymatic digestion and cultured adhered to the plastic plate. After two passages the cells were characterized by flow cytometry and immunofluorescent analysis. Adypogenesis, osteogenesis and chondrogenesis was induced to test the mesodermic potential of this population. Chondrogenic process was performed using our model which consisted in growing the cells during two days in medium with FCS 15%. After 2 days the medium was replaced by a medium with KO serum and TGF-β3. Spheroids were formed by two days in culture and this three-dimensional structure help to produce the characteristic protein which form part of the extra-cellular matrix of cartilage. The spheroids were frozen in OCT at 4, 7, 14, 28 and 46 days in defined medium culture for a posterior protein and genetic expression by immunohistochemistry and RT-PCR analysis. Results: The cells were positive for undifferentiated markers like OCT4, STRO1 and Nanog and for MSC markers like CD90 (90%), CD44 (25%), CD69 (12%) and CD106 (12%), whereas they were negative for haematopoietic markers like CD34 and CD45 (less than 4% and 5% respectively). Using a commercial medium to induce adipogenesis and osteogenesis, we obtained 100% differ-entiation of both of them confirmed by staining with Oil Red O and Alizarin Red respectively. We carried out RT-PCR and immunohistochemistry analysis to test expression of SOX9, type II collagen, type I collagen and C-20 aggrecan which are proteoglycan compounds of extra-cellular matrix and all of them were positive as soon as after 4 days in culture. Expressions of type X collagen and MMP-13 proteins also were measured raising their expression as well as increase the time in culture. Methods: Human STRO-3+ MPC were maintained in monolayer or micromass cultures (mmc) for up to 10 days in the absence and presence of PPS at concentrations of 0.1, 0.5, 1.0, 2.5, 5.0, 10.0, and 20 μg/ml. MPC proliferation and viability was assessed using the WST-1 mitochondral dehydrogenase cleavage assay and by the incorporation of 3H-Thymidine into macromolecular DNA in both culture systems. The capacity of PPS to protect MPC from IL4/INF-γ induced apoptosis was also evaluated using flow cytometry. Proteoglycan (PG) biosynthesis was monitored in mmc by the incorporation of 35SO4 into glycosaminoglycans (35S-GAGs) on days 4, 5 and 6 post culture initiation. The relative stimulatory effects of hyaluronan (HA) or dextran sulfate (DS) on PG synthesis was also examined and compared to PPS in day 5 mmc. The effects of PPS on the levels of bound and unbound HA in MPC in mmc was quantified by an ELISA and the deposition of type II collagen in the matrix assessed using a COL-II Mab and immuno-staining of the fixed cultures on day 10. The ability of PPS to modulate MPC osteogenic or adipogenic differentiation was investigated by co-culturing the cells in the respective inductive culture media for 28 days. Gene expression by MPC in micromass cultures was determined on days 7 and 10 by Real Time and RT-PCR. Results: On applying the WST-1 assay to day 6 monolayer cultures it was found that PPS markedly stimulated MPC proliferation with significant effects being observed at concentrations of 1-10 μg/ml (p<0.01). However, DNA synthesis by MPC after 4 days in mmc, showed a maximal stimulation by PPS at 1-2.5 μg/ml (p<0.005). A 38% reduction in MPC apoptosis was obtained in the presence of 1-10 μg/ml PPS. In 4-5 day MPC mmc, 5 μg/ml PPS stimulated PG synthesis by 100% more than control (p<0.005) while HA and DS at 5 μg/ml and greater inhibited PG synthesis (p<0.005). In 10 day MPC mmc, PPS promoted maximal Type II collagen deposition in the matrix at 5 μg/ml while maximal deposition of HA, relative to controls, occurred with 20 μg/ml PPS (p<0.005). The results of the bioassays examining cartilage matrix production by MPC in the presence of PPS were supported by the Real Time and RT-PCR gene expression studies using primers for Aggrecan, COL-II, SOX-9 and other genes. Notably, while able to stimulate chondrogenic differentiation of MPC, PPS at concentrations in excess of 1.0 μg/ml inhibited osteogenic differentiation of MPC (p<0.01). Conclusions: These results confirmed that PPS at low in-vitro concentrations promoted early proliferation and chondrogenesis of MPC while also blocking its potential to undergo osteogenic differentiation. On the basis of the published literature and our preliminary unpublished findings we propose that the promotion of MPC chondrogenesis by PPS may be mediated by the ability of this agent to enhance degradation of IGFBP-3 by ADAM-12s. Purpose: Osteoarthritis (OA) is a multifactorial disease characterized by destruction of the articular cartilage due to environmental, mechanical and genetic components. The genetics of OA is complex and is not completely understood. Recent work has demonstrated the importance of microRNAs (miRNAs) in cartilage function. MiRNAs are a class of small noncoding RNAs that regulate gene expression and are involved in different cellular process: apoptosis/proliferation, development, glucose and lipid metabolism. The aim of this study was identify and characterize the expression profile of miRNAs in normal and OA chondrocytes and to determine their role in the chondrocyte biology. Methods: Chondrocytes were obtained from 1 healthy donor and from 1 OA patient. After the first passage, the cells were moved to aggregate culture for a week. Evaluation of in vitro aggregate culture was carried out using histochemical (hematoxylin-eosin, Alcian Blue, Safranin O and Masson Tricromic) and immunohistochemical (Aggrecan, Collagen Type I and II) stainings. MicroR-NAs were extracted with miRVana Isolation kit and analyzed at the CNIO Core Facilities (Madrid, Spain) using the Agilent Human miRNA Microarray. Raw microarray data were normalized and analyzed using Agilent FeatureExtraction (FE) Software and GeneSpring GX10. Of the 723 human miRNAs, a list of the differentially expressed miRNAs in normal and OA chondrocytes was bioinformatically analyzed (using Sanger miRBase, microRNA.org,
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